Yazar "Tokuc, B." seçeneğine göre listele
Listeleniyor 1 - 13 / 13
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Association analysis between A163G and T245G gene polymorphisms of osteoprotegerin and bone mineral density in Turkish postmenopausal women(Wiley, 2017) Palabiyik, O.; Ozdemir, F.; Tokuc, B.; Sipahi, T.; Kabayel, D. Demirbag[Abstract Not Available]Öğe Determination of the concentration and composition of PM10 in Edirne-Turkey(Oxford Univ Press, 2018) Gul, I.; Yorulmaz, F.; Tokuc, B.[Abstract Not Available]Öğe Effect of high protein diet and exercise on cardiac Aquaporin 7 expression(Wiley-Blackwell, 2014) Palabiyik, O.; Karaca, A.; Vardar, S. A.; Tastekin, E.; Yamasan, B. E.; Tokuc, B.; Sipahi, T.[Abstract Not Available]Öğe Evaluation of patient rights practices in a developing country: the Edirne model for the implementation of patient rights in Turkey(B M J Publishing Group, 2010) Saracoglu, G. V.; Tokuc, B.; Guler, F.; Gul, H.Objective The aim of this study was to examine the development of the implementation of patient rights and the practical course of patient rights legislation in Edirne, as well as the verbal and written applications to relevant departments between 2004 and 2008. Methods The present study was a descriptive, retrospective and cross-sectional study. The data of the study were obtained by retrospectively reviewing records of written complaints to patient rights units and on-site solutions between 2004, the year of establishment of these units, and 2008. Results The incidence of written and verbal complaints were calculated to be 23.1 in 100 000 and 137.9 in 100 000, respectively. The increase was 102.2% for on-site solutions, whereas it was calculated as 97.8% for written applications. It was noticed that the rate of violation judgements was high (42.5% (17/40)) in the first year the Edirne State Hospital patient rights committee was established. Conclusions Possible problems encountered during the presentation of health services can be solved by the implementation of patient rights under the legislative guarantee. The implementation of patient rights should be considered as reflections of a socialised government on health services.Öğe An evaluation of the relationship between premature mortality and socioeconomic factors in Turkey(Oxford Univ Press, 2018) Tokuc, B.; Eskiocak, M.; Mimaroglu, A.; Ozkutukcu, M.; Varol, G.[Abstract Not Available]Öğe Is provision of family medicine units in Turkey between 2010 and 2014 on an equitable basis?(Oxford Univ Press, 2016) Tokuc, B.; Eskiocak, M.; Arkant, C.; Cokluk, S.[Abstract Not Available]Öğe Knowledge, Attitudes and Practice about Cervical Cancer Screening among Women Living in Edirne(Oxford Univ Press, 2017) Tokuc, B.; Eren, F.; Saracoglu, G. Varol[Abstract Not Available]Öğe MORTALITY AND RELATED FACTORS IN ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA(Ferrata Storti Foundation, 2014) Demir, M.; Umit, E.; Uyanik, S.; Maden, M.; Tokuc, B.; Puyan, F.; Pamuk, G.[Abstract Not Available]Öğe PAGET'S DISEASE OF THE BONE FOUND INCIDENTALLY ON F-18 FDG PET/CT: CLINICAL SIGNIFICANCE AND DIFFERENTIAL DIAGNOSTIC CRITERIA(Editura Acad Romane, 2023) Uestuen, F.; Ustabasioglu, F. E.; Tokuc, B.; Buelbuel, B. Yimaz; Celik, M.; Aytuerk, S.Background. Paget Disease (PD) is usually asymptomatic and discovered incidentally, it is known that it is exhibited low to high grade increased F-18 FDG uptake. Aim. In this study, we investigated the distinguishability of FDG PET/CT in incidental PD cases from other bone diseases and at different stages of the disease. Patients and Methods. In this cross-sectional, descriptive study, Paget identification associated with PET/CT reports was found in 69 of 18,119 studies (similar to 3.8%). Of the 45 patients (33 males and 12 females) eligible for inclusion in the study, 35.6% had monostotic and 64.4% had polyostotic disease (p>0.5). There was no statistically significant difference in biochemical parameters between groups. Results. According to the radiological appearance of the patients, 36 were in the mixed stage and 9 were in the blastic stage. Only the difference in ALP and creatinine values between the groups was statistically significant. SUVmax, SUVmean and HU values were found to be statistically significantly higher in pagetoid bones compared to control bone lesions. For SUVmax for PD bone lesion we found the 2.55 cutoff point with a sensitivity of 91% and a specificity of 84%. Conclusion. The specific radiological appearance of bone lesions and the evaluation of metabolic activity compared to normal bone seem to help differentiate PD from other lesions. Prospective studies are needed in the differentiation of FDG's disease stage and treatment response evaluation. The ability to differentiate between benign and malignant FDG avid bone lesions in oncological patients' enables appropriate patient management, including avoiding unnecessary additional invasive procedures such as bone biopsy.Öğe People who are living in geographically disadvantaged: health promotion on health system(Oxford Univ Press, 2018) Saracoglu, G. Varol; Tokuc, B.; Dilek, F.[Abstract Not Available]Öğe The prevalance of hepatitis B among health personnel: A systematic review(Oxford Univ Press, 2018) Selcuk, E. G.; Ekuklu, G.; Tokuc, B.[Abstract Not Available]Öğe Staging and Indices measured with 18F-FDG PET/CT as a predictor of survival in Non-hodgkin's lymphoma(Springer, 2015) Serim, B. Dirlik; Umit, E.; Ustun, F.; Tokuc, B.; Demir, M.; Altun, G. Durmus[Abstract Not Available]Öğe Tumor characteristics of lung cancer in predicting axillary lymph node metastases(Elsevier Espana Slu, 2019) Ustun, F.; Tokuc, B.; Tastekin, E.; Altun, G. DurmusObjective: In lung cancer, axillary lymph node metastases (ALM) are rare, and according to the 8th grading system, it is classified as M1b disease. The aim of this study is to evaluate 1 ) the presence of ALM and2) the effect of the primary tumors characteristics on the development of ALM. Methods: We performed a descriptive cross-sectional study, with retrospective revision, to identify ALM. Results: There were 157 patients included in this analysis: ALM (63 patients) and control group (94 patients). The presence of extrathoracic lymph node, contralateral pulmonary parenchymal and distant metastasis and all SUVmax values were significantly higher in the study group versus the control group (P< 0.05). The SUVmax value of the primary tumor was not a predictor of ALM. According to the primary histopathologic diagnosis, small cell lung cancer was found to cause ALM development 3.4 times as much as squamous cancer (SQC) (OR: 3.40 [95% CI 1.3-10.20], P= 0.029) and adenocarcinoma group was found to cause ALM development 4 times as much as SQC (OR: 4.02 [95% CI 1.73-9.34], P= 0.001). The likelihood of developing ALM was significantly higher in tumors located in the central and upper lobe versus the lower lobe. Conclusion: The finding of ALM on PET/CT images, the necessity of histopathologic confirmation is determined according to the results of primary tumor localization, primary tumor histopathology, M stage on PET/CT imaging, localization of ALM according to primary tumor, and N stage on PET/CT imaging. (C) 2018 Sociedad Espanola de Medicina Nuclear e Imagen Molecular. Published by Elsevier Espana, S.L.U. All rights reserved.
